Mammalian Mediator 19 Mediates H1299 Lung Adenocarcinoma Cell Clone Conformation, Growth, and Metastasis

  • Xu, Lu-Lu (Department of Respiratory Medicine, the First Affiliated Hospital of Chongqing Medical University) ;
  • Guo, Shu-Liang (Department of Respiratory Medicine, the First Affiliated Hospital of Chongqing Medical University) ;
  • Ma, Su-Ren (Department of Respiratory Medicine, the First Affiliated Hospital of Chongqing Medical University) ;
  • Luo, Yong-Ai (Department of Respiratory Medicine, the First Affiliated Hospital of Chongqing Medical University)
  • Published : 2012.08.31


Mammalian mediator (MED) is a multi-protein coactivator that has been identified by several research goups. The involvement of the MED complex subunit 19 (MED 19) in the metastasis of lung adenocarcinoma cell line (H1299), which expresses the MED 19 subunit, was here investigated. When MED 19 expression was decreased by RNA interference H1299 cells demonstrated reduced clone formation, arrest in the S phase of the cell cycle, and lowered metastatic capacity. Thus, MED 19 appears to play important roles in the biological behavior of non-small cell lung carcinoma cells. These findings may be important for the development of novel lung carcinoma treatments.


  1. Klein CA (2008). Cancer. The metastasis cascade. Science, 321, 1785-7.
  2. Baidoobonso SM, Guidi BW, Myers LC (2007). Med19 (Rox3) regulates Intermodule interactions in the Saccharomyces cerevisiae mediator complex. J Biol Chem, 282, 5551-9.
  3. Bernas T, Dobrucki J (2002). Mitochondrial and nonmitochondrial reduction of MTT: interaction of MTT with TMRE, JC-1, and NAO mitochondrial fluorescent probes. Cytometry, 47, 236-42.
  4. Bjorklund S, Gustafsson CM (2005). The yeast Mediator complex and its regulation. Trends Biochem Sci, 30, 240-4.
  5. Boyer TG, Martin ME, Lees E, Ricciardi RP, Berk AJ (1999). Mammalian Srb/Mediator complex is targeted by adenovirus E1A protein. Nature, 399, 276-9.
  6. Chiang AC, Massague J (2008). Molecular basis of metastasis. N Engl J Med, 359, 2814-23.
  7. Conaway RC, Sato S, Tomomori-Sato C, Yao T, Conaway JW (2005). The mammalian Mediator complex and its role in transcriptional regulation. Trends Biochem Sci, 30, 250-5.
  8. Ding N, Tomomori-Sato C, Sato S, et al (2009). MED19 and MED26 are synergistic functional targets of the RE1 silencing transcription factor in epigenetic silencing of neuronal gene expression. J Biol Chem, 284, 2648-56.
  9. Guidi BW, Bjornsdottir G, Hopkins DC, et al (2004) Mutual targeting of mediator and the TFIIH kinase Kin28. J Biol Chem, 279, 29114-20.
  10. Gu W, Malik S, Ito M, et al (1999). A novel human SRB/ MED-containing cofactor complex, SMCC, involved in transcription regulation. Mol Cell, 3, 97-108.
  11. Hoffmann A, Baltimore D (2006). Circuitry of nuclear factor kappaB signaling. Immunol Rev, 210, 171-86.
  12. Kim YJ, Bjorklund S, Li Y, Sayre MH, Kornberg RD (1994). A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II. Cell, 77, 599-608.
  13. Long N, Moore MA, Chen W, et al (2010). Cancer epidemiology and control in north-East Asia - past, present and future. Asian Pac J Cancer Prev, Suppl 2, 107-48.
  14. Mittler G, Kremmer E, Timmers HT, Meisterernst M (2001). Novel critical role of a human Mediator complex for basal RNA polymerase II transcription. EMBO Rep, 2, 808-13
  15. Myers LC, Kornberg RD (2000). Mediator of transcriptional regulation. Annu Rev Biochem, 69, 729-49.
  16. Orphanides G, Lagrange T, Reinberg D (1996). The general transcription factors of RNA polymerase II. Genes Dev, 10, 2657-83.
  17. Ramaswamy S, Ross KN, Lander ES, Golub TR (2003). A molecular signature of metastasis in primary solid tumors. Nat Genet, 33, 49-54.
  18. Sato S, Tomomori-Sato C, Banks CA, et al (2003). Identification of mammalian Mediator subunits with similarities to yeast Mediator subunits Srb5, Srb6, Med11, and Rox3. J Biol Chem, 278, 15123-7.
  19. Sato S, Tomomori-Sato C, Parmely TJ, et al (2004). A set of consensus mammalian mediator subunits identified by multidimensional protein identification technology. Mol Cell, 14, 685-91.
  20. Tokusumi Y, Ma Y, Song X, Jacobson RH, Takada S (2007). The new core promoter element XCPE1 (X Core Promoter Element 1) directs activator-, mediator-, and TATA-binding protein-dependent but TFIID-independent RNA polymerase II transcription from TATA-less promoters. Mol Cell Biol, 27, 1844-58.
  21. Wang W, Zhang N, Wang J, Bu XM, Zhao CH (2011). Inhibition of proliferation, viability, migration and invasion of gastric cancer cells by Aurora-A deletion. Asian Pac J Cancer Prev, 12, 2717-20.
  22. Wilson AP (2000). Cytotoxicity and Viability Assays in Animal Cell Culture: A Practical Approach. Oxford University Press: Oxford.
  23. Yoshida BA, Sokoloff MM, Welch DR, Rinker-Schaeffer CW (2000). Metastasis-suppressor genes: a review and perspective on an emerging field. J Natl Cancer Inst, 92, 1717-30.

Cited by

  1. Knockdown of Med19 Suppresses Proliferation and Enhances Chemo-sensitivity to Cisplatin in Non-small Cell Lung Cancer Cells vol.16, pp.3, 2015,
  2. Knockdown of Mediator Complex Subunit 19 Suppresses the Growth and Invasion of Prostate Cancer Cells vol.12, pp.1, 2017,